Literature DB >> 10543413

Pleiotropic effects of thyroid stimulating hormone in a differentiated thyroid cancer cell line. Studies on proliferation, thyroglobulin secretion, adhesion, migration and invasion.

A Zielke1, S Hoffmann, U Plaul, Q Y Duh, O H Clark, M Rothmund.   

Abstract

Thyroid stimulating hormone (TSH) causes differentiation and epidermal growth factor (EGF) causes dedifferentiation of thyroid cells in vitro. In undifferentiated thyroid cancer cell lines, TSH stimulates tumor cell migration and invasion, a dedifferentiated function, presumably due to an escape of tumor cells from the control of differentiating growth factors. In a highly differentiated thyroid carcinoma cell line of Hürthle cell origin (XTC), we tested the hypothesis that TSH would stimulate thyroglobulin secretion (a differentiated function) more than EGF, and EGF would stimulate invasion (a de-differentiated function) more than TSH. Proliferation, adhesion, cell migration and invasion were measured by the MTT assay, human thyroglobulin by RIA and protease activity by substrate-gel zymography. TSH induced differentiated morphologic changes in XTC cells and stimulated secretion of human thyroglobulin in a dose dependent manner, whereas EGF did not. The effects of TSH on growth, adhesion, migration and invasion were dose dependent and biphasic, with an increase at low and a decrease at high concentrations of TSH. These effects were always more pronounced than those observed with EGE Gelatinolytic activity, consistent with metalloproteinase activity was revealed by zymography, but the pattern of secretion was not altered by neither TSH nor EGF. These results suggest, that TSH has pleiotropic effects on differentiated thyroid cancer cells in vitro that involve differentiated morphology and function but also affect features commonly associated with the malignant in vitro phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543413     DOI: 10.1055/s-0029-1212127

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.

Authors:  K S Banu; P Govindarajulu; M M Aruldhas
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

2.  Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.

Authors:  S Hoffmann; K Maschuw; I Hassan; A Wunderlich; S Lingelbach; A Ramaswamy; L C Hofbauer; A Zielke
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

3.  Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.

Authors:  Michael W Yeh; Jean-Philippe Rougier; Jin-Woo Park; Quan-Yang Duh; Mariwil Wong; Zena Werb; Orlo H Clark
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

4.  Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity.

Authors:  Yiyu Dong; Yongxing Gong; Fengshen Kuo; Vladimir Makarov; Ed Reznik; Gouri J Nanjangud; Omer Aras; Huiyong Zhao; Rui Qu; James A Fagin; Eric J Sherman; Bin Xu; Ronald Ghossein; Timothy A Chan; Ian Ganly
Journal:  Mol Cancer Ther       Date:  2021-11-17       Impact factor: 6.009

5.  Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.

Authors:  Eleonore Fröhlich; Peter Brossart; Richard Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-24       Impact factor: 9.236

6.  P21-activated kinase 4 involves TSH induced papillary thyroid cancer cell proliferation.

Authors:  Xiaochen Xie; Xiaoguang Shi; Haixia Guan; Qiqiang Guo; Chenling Fan; Wenwu Dong; Guiling Wang; Feng Li; Zhongyan Shan; Liu Cao; Weiping Teng
Journal:  Oncotarget       Date:  2017-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.